CGB 0.00% 2.1¢ cann global limited

Ann: A World First for MCL in Autoimmune Disease Reasearch, page-38

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,872 Posts.
    lightbulb Created with Sketch. 3205
    The positives from todays announcement imo.

    1) Committing 3 million dollars over three years suggests strong cash flow & sales from our only current source of income..Hemp.

    2) A company willing to invest in it's future. I'm sure like all medical fields it will constantly evolve & to ensure success for share holders staying at the fore front of research & technology will be critical to long term stability.

    3) The committments with Israel & Canntabb of million dollars suggests strong cash flow from Vitahemp, if this is in fact the case hopefully we can avoid any capital raisings in the near future. Unlike other mm companies it would appear we are going to have a strong cash flow from our hemp proping us up. Other mm companies may have to cr & dillute with no stream of income until their medical marijuana products can produce cash flow.

    Looking forward to March/April & onwards.
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.